Skip to Content

Treatment of Severe Atopic Dermatitis (AD)

A new area of treatment options makes it possible to choose evidence-based drugs with a more favorable risk/benefit profile for patients with atopic dermatitis. According to Dr. Pedro Mendes-Bastos, we first must select the right, and most severely affected, patients. Secondly, we are to choose between drugs. Get his elaboration in this EADV 2022 MEDtalk.

Pedro Mendes-Bastos

Få tillgång till artikeln

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Back to top